A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

NCT07463521 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Ocular Myasthenia Gravis

Interventions

DRUG: Rozanolixizumab
DRUG: Placebo

Sponsor

UCB Biopharma SRL